Padagis US LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 3940 Quebec Ave N, Minneapolis, Minnesota (MN) 55427, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 2127022 · DUNS 967694121
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-04-08
- VAIDrug Quality Assurance2024-09-06
- NAIBioresearch Monitoring2024-01-31
- NAIBioresearch Monitoring2023-05-05
- VAIDrug Quality Assurance2022-02-18
- NAIBioresearch Monitoring2019-10-23
- VAIDrug Quality Assurance2017-07-07
- NAIDrug Quality Assurance2013-11-06
- NAIBioresearch Monitoring2013-02-06
- VAIDrug Quality Assurance2013-02-06
- VAIDrug Quality Assurance2010-11-19
- VAIDrug Quality Assurance2009-03-20
Drugs this plant is listed as making
4 distinct drugs across 5 products name this site in their FDA label.
- ChlorothiazideSalix Pharmaceuticals, Inc
- hydrocortisoneSalix Pharmaceuticals, Inc
- Hydrocortisone AcetateSalix Pharmaceuticals, Inc
- Triamcinolone AcetonidePadagis Israel Pharmaceuticals Ltd
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.